Negative urgency, distress tolerance, and symptoms of substance use, eating, and borderline personality disorders in treatment‐seeking young people
Journal of Clinical Psychology · 2024
DOI: 10.1002/jclp.23579 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Psychology, 2024. Verfasst von Sophie Mattingley und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Psychology, Deakin University, Geelong, Victoria, Australia. Hauptthemen laut MEDLINE: Borderline Personality Disorder, Feeding and Eating Disorders, Substance-Related Disorders. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
Negative urgency (NU) and distress tolerance (DT) are two similar yet distinct constructs with putative transdiagnostic relevance, particularly across psychopathology characterized by impulsivity (e.g., substance use disorders [SUD], eating disorders featuring binging and/or purging ED‐B/P, and borderline personality disorder [BPD]). Yet, there remains a lack of research into NU and DT across SUD, ED‐B/P, and BPD symptomatology in clinical populations. The present study sought to elucidate the transdiagnostic utility of NU and DT across impulsive‐type psychology by examining the unique and interactive roles of NU and DT across SUD, ED‐B/P, and BPD symptomatology within a treatment‐seeking sample of young people.
Method
Participants ( N = 385; 62.3% female; aged 16–25 years) were recruited from youth health services across Melbourne, Australia. Participants completed an online survey including self‐report measures of NU and DT as well as SUD, ED‐B/P, and BPD symptoms. Mixed effects logistic regression was used to explore unique and interactive associations of NU and DT with symptoms.
Results
Both NU (adjusted odds ratio [OR adj ] = 1.22; 95% confidence interval [CI] = [1.16, 1.28]) and global DT (OR adj = 0.59; 95% CI = [0.47, 0.74]) uniquely predicted symptoms. However, associations with global DT and most of its components differed across psychopathology types. No significant interactions between NU and DT in predicting symptoms were found.
Conclusions
These results support the transdiagnostic utility of NU across SUD, ED‐B/P, and BPD, while suggesting the role of DT across these disorders is more nuanced. These findings have important implications for NU and DT as potential intervention targets.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Psychology, Deakin University, Geelong, Victoria, Australia.
- Centre of Drug Use, Addictive and Antisocial Behavior Research, Deakin University, Geelong, Victoria, Australia.
- Centre for Adolescent Health, Murdoch Children's Research Institute, Melbourne, Victoria, Australia.
- Monash Addiction Research Centre (MARC), Eastern Health Clinical School, Monash University, Melbourne, Victoria, Australia.
- Turning Point, Eastern Health, Richmond, Victoria, Australia.
ORCID-Profile: Sophie Mattingley, Kate Hall
Zitieren
APA
Mattingley, S., Youssef, G. J., Graeme, L., Sloan, E., Manning, V., & Hall, K. (2024). Negative urgency, distress tolerance, and symptoms of substance use, eating, and borderline personality disorders in treatment‐seeking young people. Journal of Clinical Psychology. https://doi.org/10.1002/jclp.23579
Vancouver
Mattingley S, Youssef GJ, Graeme L, Sloan E, Manning V, Hall K. Negative urgency, distress tolerance, and symptoms of substance use, eating, and borderline personality disorders in treatment‐seeking young people. Journal of Clinical Psychology. 2024. doi:10.1002/jclp.23579
BibTeX
@article{Mattingley2024,
author = {Mattingley, Sophie and Youssef, George J and Graeme, Liam and Sloan, Elise and Manning, Victoria and Hall, Kate},
title = {Negative urgency, distress tolerance, and symptoms of substance use, eating, and borderline personality disorders in treatment‐seeking young people},
journal = {Journal of Clinical Psychology},
year = {2024},
doi = {10.1002/jclp.23579}
}
EUVIMED